Semaglutide may lower risk of serious complications in high-risk diabetes

Keyword: Endothelial Dysfunction

Publisher: Medical News Today

Published: Jul 2, 2026

A new study suggests GLP-1 receptor agonists, such as Ozempic and Wegovy, are associated with better overall outcomes in people with type 2 diabetes and peripheral artery disease (PAD), compa… [+8196 chars]

Read Full Story ↗

Related Content

Related Story HLA-DRB1 and HLA-DQB1 genetic polymorphisms and susceptibility to coronary atherosclerosis in a Northeast Chinese Population: A case-control study

Plos.org
Related Story Association of triglyceride-glucose index (TyG) and a body shape index (ABSI) with cognitive decline and dementia risk

Plos.org
Related Story The Guts key role in optimizing kidney health: ARA Integrative and Functional Medicine: Integrative Medicine

Araintegrative.com